Histomorphometric analysis on day 14
. | ObS/BS, % . | OS/BS, % . | MS/BS, % . | MAR, μm/d . | BFR/BS, μm3/μm2/y . |
---|---|---|---|---|---|
Untreated BDF1 | 17.3 ± 1.7 | 21.6 ± 2.8 | 25.7 ± 3.4 | 2.3 ± 0.3 | 24.7 ± 2.8 |
BMT | 17.2 ± 6.5 | 15.3 ± 3.1 | 23.5 ± 7.5 | 1.5 ± 0.3 | 17.1 ± 6.6 |
GVHD | NC | NC | NC | NC | NC |
. | ObS/BS, % . | OS/BS, % . | MS/BS, % . | MAR, μm/d . | BFR/BS, μm3/μm2/y . |
---|---|---|---|---|---|
Untreated BDF1 | 17.3 ± 1.7 | 21.6 ± 2.8 | 25.7 ± 3.4 | 2.3 ± 0.3 | 24.7 ± 2.8 |
BMT | 17.2 ± 6.5 | 15.3 ± 3.1 | 23.5 ± 7.5 | 1.5 ± 0.3 | 17.1 ± 6.6 |
GVHD | NC | NC | NC | NC | NC |
Data are mean plus or minus SE (n = 4 per group).
ObS/BS indicates osteoblast surface per bone surface; OS/BS, osteoid surface per bone surface; MS/BS, mineralized surface per bone surface; MAR, mineral apposition rate; BFR/BS, bone formation rate per bone surface; and NC, not calculated.